210 related articles for article (PubMed ID: 7916648)
1. Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach.
Austruy E; Cohen-Salmon M; Antignac C; Béroud C; Henry I; Nguyen VC; Brugières L; Junien C; Jeanpierre C
Cancer Res; 1993 Jun; 53(12):2888-94. PubMed ID: 7916648
[TBL] [Abstract][Full Text] [Related]
2. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
[TBL] [Abstract][Full Text] [Related]
3. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
4. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
5. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
7. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
[TBL] [Abstract][Full Text] [Related]
8. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.
Brenner B; Wildhardt G; Schneider S; Royer-Pokora B
Oncogene; 1992 Jul; 7(7):1431-3. PubMed ID: 1320246
[TBL] [Abstract][Full Text] [Related]
9. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
10. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
[TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
Gessler M; Poustka A; Cavenee W; Neve RL; Orkin SH; Bruns GA
Nature; 1990 Feb; 343(6260):774-8. PubMed ID: 2154702
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain.
Sharma PM; Yang X; Bowman M; Roberts V; Sukumar S
Cancer Res; 1992 Nov; 52(22):6407-12. PubMed ID: 1330293
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study.
Paik S; Rosen N; Jung W; You JM; Lippman ME; Perdue JF; Yee D
Lab Invest; 1989 Nov; 61(5):522-6. PubMed ID: 2554059
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
[TBL] [Abstract][Full Text] [Related]
18. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
19. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
20. Presence of the long chain form of polysialic acid of the neural cell adhesion molecule in Wilms' tumor. Identification of a cell adhesion molecule as an oncodevelopmental antigen and implications for tumor histogenesis.
Roth J; Zuber C; Wagner P; Blaha I; Bitter-Suermann D; Heitz PU
Am J Pathol; 1988 Nov; 133(2):227-40. PubMed ID: 2461089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
